| Ident. | Authors (with country if any) | Title |
|---|
| 000091 (2020) |
Guillaume Decarriere [France] ; Thomas Barnetche [France] ; Bernard Combe [France] ; Cécile Gaujoux-Viala [France] ; Cédric Lukas [France] ; Jacques Morel [France] ; Claire Daien [France] | The most appropriate conventional DMARD to combine with different advanced therapies in rheumatoid arthritis: a systematic literature review with meta-analysis. |
| 000163 (2020) |
Jacques Morel [France] ; Marie Locci [France] ; Frédéric Banal [France] ; Bernard Combe [France] ; Grégoire Cormier [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Christian Marcelli [France] ; Thao Pham [France] ; Stéphanie Rist [France] ; Elizabeth Solau Gervais [France] ; Jean Sibilia [France] ; Cédric Lukas [France] | Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registry. |
| 000367 (2020) |
Charlotte Hua [France] ; Frank Buttgereit [Allemagne] ; Bernard Combe [France] | Glucocorticoids in rheumatoid arthritis: current status and future studies |
| 000E47 (2019) |
Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France] | Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study |
| 001074 (2018) |
Bernard Combe [France] ; S. Lula ; C. Boone ; P. Durez [Belgique] | Effects of biologic disease-modifying anti-rheumatic drugs on the radiographic progression of rheumatoid arthritis: a systematic literature review. |
| 001532 (2017-11-03) |
Alain Saraux [France] ; René-Marc Flipo [France] ; Bernard Combe [France] ; Jacques Tebib [France] ; Christelle Baffie [France] ; Isabelle Idier [France] ; Alain Cantagrel [France] | Factors influencing the prescription of Tocilizumab alone or in combination with Dmards in rheumatoid arthritis patients in a real life setting. Pooled analysis of 2 observational studies. |
| 001533 (2017-11-03) |
Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Arnaud Constantin [Royaume-Uni] ; Thomas Bardin [France] ; Alain Cantagrel [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Elodie Perrodeau [France] ; Philippe Ravaud [France] ; Xavier Mariette [France] | Corticosteroid Sparing Effect of Non-TNF Targeted Biologics, Rituximab, Abatacept and Tocilizumab in Common Practice: Data from 3183 Patients Enrolled in the French Society of Rheumatology Registries |
| 001534 (2017-07-14) |
Jacques Morel [France] ; Arnaud Constantin [France] ; Gabriel Baron [France] ; Emmanuelle Dernis [France] ; René-Marc Flipo [France] ; Stéphanie Rist [France] ; Bernard Combe [France] ; Jacques-Eric Gottenberg [France] ; Thierry Schaeverbeke [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Maxime Dougados [France] ; Alain Saraux [France] ; Xavier Mariette [France] ; Philippe Ravaud [France] ; Jean Sibilia [France] | Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French registry REGATE |
| 001689 (2017) |
Jacques Morel [France] ; Arnaud Constantin [France] ; Gabriel Baron [France] ; Emmanuelle Dernis ; René Marc Flipo ; Stéphanie Rist ; Bernard Combe [France] ; Jacques Eric Gottenberg [France] ; Thierry Schaeverbeke ; Martin Soubrier ; Olivier Vittecoq ; Maxime Dougados [France] ; Alain Saraux ; Xavier Mariette [France] ; Philippe Ravaud [France] ; Jean Sibilia [France] | Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE. |
| 001733 (2017) |
Claire Immediato Daien [France] ; Charlotte Hua [France] ; Bernard Combe [France] ; Robert Landewe [Pays-Bas] | Non-pharmacological and pharmacological interventions in patients with early arthritis: a systematic literature review informing the 2016 update of EULAR recommendations for the management of early arthritis |
| 001788 (2017) |
Cynthia Nourisson [France] ; Martin Soubrier [France] ; Aurélien Mulliez [France] ; Athan Baillet [France] ; Thomas Bardin [France] ; Alain Cantagrel [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Olivier Vittecoq [France] ; Philippe Ravaud [France] ; Jacques-Eric Gottenberg [France] ; Xavier Mariette [France] ; Anne Tournadre [France] | Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the ‘ORA’ registry |
| 001837 (2017) |
Josef S. Smolen [Autriche] ; Robert Landewé [Pays-Bas] ; Johannes Bijlsma [Pays-Bas] ; Gerd Burmester [Allemagne] ; Katerina Chatzidionysiou [Suède] ; Maxime Dougados [France] ; Jackie Nam [Royaume-Uni] ; Sofia Ramiro [Pays-Bas] ; Marieke Voshaar [Pays-Bas] ; Ronald Van Vollenhoven [Pays-Bas] ; Daniel Aletaha [Autriche] ; Martin Aringer [Allemagne] ; Maarten Boers [Pays-Bas] ; Chris D. Buckley [Royaume-Uni] ; Frank Buttgereit [Allemagne] ; Vivian Bykerk [États-Unis] ; Mario Cardiel [Mexique] ; Bernard Combe [France] ; Maurizio Cutolo [Italie] ; Yvonne Van Eijk-Hustings [Pays-Bas] ; Paul Emery [Pays-Bas] ; Axel Finckh [Suisse] ; Cem Gabay [Suisse] ; Juan Gomez-Reino [Espagne] ; Laure Gossec [France] ; Jacques-Eric Gottenberg [France] ; Johanna M W. Hazes [Pays-Bas] ; Tom Huizinga [Pays-Bas] ; Meghna Jani [Royaume-Uni] ; Dmitry Karateev [Russie] ; Marios Kouloumas [Suisse] ; Tore Kvien [Norvège] ; Zhanguo Li [République populaire de Chine] ; Xavier Mariette [France] ; Iain Mcinnes [Royaume-Uni] ; Eduardo Mysler [Argentine] ; Peter Nash [Australie] ; Karel Pavelka [République tchèque] ; Gyula Po R [Hongrie] ; Christophe Richez [France] ; Piet Van Riel [Pays-Bas] ; Andrea Rubbert-Roth [Allemagne] ; Kenneth Saag [États-Unis] ; Jose Da Silva [Portugal] ; Tanja Stamm [Autriche] ; Tsutomu Takeuchi [Japon] ; René Westhovens [Belgique] ; Maarten De Wit [Pays-Bas] ; Désirée Van Der Heijde [Pays-Bas] | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. |
| 001891 (2017) |
Francisco Espinoza [Chili] ; Pierre Le Blay [Chili] ; Bernard Combe [Chili] | Biologic Disease-modifying Antirheumatic Drug (bDMARD)-induced Neutropenia: A Registry from a Retrospective Cohort of Patients with Rheumatic Diseases Treated with 3 Classes of Intravenous bDMARD. |
| 001A97 (2016) |
Josef S. Smolen [Autriche] ; Joel M. Kremer [États-Unis] ; Carol L. Gaich [États-Unis] ; Amy M. Delozier [États-Unis] ; Douglas E. Schlichting [États-Unis] ; Li Xie [États-Unis] ; Ivaylo Stoykov [États-Unis] ; Terence Rooney [États-Unis] ; Paul Bird [Australie] ; Juan Miguel Sánchez Burs N [Espagne] ; Mark C. Genovese [États-Unis] ; Bernard Combe [France] | Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON) |
| 001E47 (2015) |
Josef S. Smolen [Autriche] ; Ferdinand C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Vivian Bykerk [États-Unis] ; Maxime Dougados [France] ; Paul Emery [Royaume-Uni] ; Tore K. Kvien [Norvège] ; M Victoria Navarro-Compán [Pays-Bas] ; Susan Oliver [Royaume-Uni] ; Monika Schoels [Autriche] ; Marieke Scholte-Voshaar [Suisse] ; Tanja Stamm [Autriche] ; Michaela Stoffer [Autriche] ; Tsutomu Takeuchi [Japon] ; Daniel Aletaha [Autriche] ; Jose Louis Andreu [Espagne] ; Martin Aringer ; Martin Bergman [États-Unis] ; Neil Betteridge [Suisse] ; Hans Bijlsma [Pays-Bas] ; Harald Burkhardt ; Mario Cardiel [Mexique] ; Bernard Combe [France] ; Patrick Durez [Belgique] ; Joao Eurico Fonseca [Portugal] ; Alan Gibofsky [États-Unis] ; Juan J. Gomez-Reino [Espagne] ; Winfried Graninger [Autriche] ; Pekka Hannonen [Finlande] ; Boulos Haraoui [Canada] ; Marios Kouloumas [Suisse] ; Robert Landewe [Pays-Bas] ; Emilio Martin-Mola [Espagne] ; Peter Nash [Australie] ; Mikkel Ostergaard [Danemark] ; Andrew Östör [Royaume-Uni] ; Pam Richards [Suisse] ; Tuulikki Sokka-Isler [Finlande] ; Carter Thorne [Canada] ; Athanasios G. Tzioufas [Grèce] ; Ronald Van Vollenhoven [Suède] ; Martinus De Wit [Suisse] ; Desirée Van Der Heijde [Pays-Bas, Royaume-Uni] | Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force |
| 001F46 (2015) |
Rachel Audo [France] ; Claire Daien [France] ; Laura Papon [France] ; Cédric Lukas [France] ; Olivier Vittecoq [France] ; Michael Hahne [France, Pays-Bas] ; Bernard Combe [France] ; Jacques Morel [France] | Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort |
| 002011 (2015) |
Claire Immediato Daïen [France] ; Sarah Gailhac [France] ; Rachel Audo [France] ; Thibault Mura [France] ; Michael Hahne [France] ; Bernard Combe [France] ; Jacques Morel [France] | High levels of natural killer cells are associated with response to tocilizumab in patients with severe rheumatoid arthritis. |
| 002041 (2015) |
Michael Schiff [États-Unis] ; Bernard Combe [France] ; Thomas Dörner [Allemagne] ; Joel M. Kremer [États-Unis] ; Thomas W. Huizinga [Pays-Bas] ; Melissa Veenhuizen [États-Unis] ; Anne Gill [États-Unis] ; Wendy Komocsar [États-Unis] ; Pierre-Yves Berclaz [Japon] ; Robert Ortmann [États-Unis] ; Chin Lee [États-Unis] | Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study |
| 002467 (2014) |
Maya H. Buch [Royaume-Uni] ; Lucia Silva-Fernandez [Espagne] ; Loreto Carmona [Espagne] ; Daniel Aletaha [Autriche] ; Robin Christensen [Danemark] ; Bernard Combe [France] ; Paul Emery [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Francis Guillemin [France] ; Tore K. Kvien [Norvège] ; Robert Landewe [Pays-Bas] ; Karel Pavelka [République tchèque] ; Kenneth Saag [États-Unis] ; Josef S. Smolen [Autriche] ; Deborah Symmons [Royaume-Uni] ; Désirée Van Der Heijde [Pays-Bas] ; Joep Welling [Pays-Bas] ; George Wells [Canada] ; Rene Westhovens [Belgique] ; Angela Zink [Allemagne] ; Maarten Boers [Pays-Bas] | Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology |
| 002711 (2013) |
Anaiz Nutz ; Charlotte Pernet ; Bernard Combe ; Jean-David Cohen | Sarcoidosis induced by tocilizumab: a paradoxical event? |
| 002745 (2013) |
Edward Keystone [Canada] ; Robert Landewé [Pays-Bas] ; Ronald Van Vollenhoven [Suède] ; Bernard Combe [France] ; Vibeke Strand [États-Unis] ; Philip Mease [États-Unis] ; Laura Shaughnessy [États-Unis] ; Brenda Vanlunen [États-Unis] ; Désirée Van Der Heijde [Pays-Bas] | Long-term safety and efficacy of certolizumab pegol in combination with methotrexate in the treatment of rheumatoid arthritis: 5-year results from the RAPID 1 trial and open-label extension |
